Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
暂无分享,去创建一个
W. Moon | M. Park | Seun-Ja Park | J. Kim | H. Kwon | J. Cheon | K. Ku | S. Song | S. Kim | Gyu Won Lee | C. Yoo | Y. Choi
[1] R. Vilaichone,et al. Improved Efficacy of Proton Pump Inhibitor – Amoxicillin – Clarithromycin Triple Therapy for Helicobacter pylori Eradication in Low Clarithromycin Resistance Areas or for Tailored Therapy , 2013, Helicobacter.
[2] Hyuk Lee,et al. [Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition]. , 2013, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[3] Jung Mogg Kim,et al. Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012 , 2013, Helicobacter.
[4] S. Boo,et al. [Clarithromycin-resistant Helicobacter pylori associated with 23S rRNA point mutations in Jeju Island]. , 2013, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[5] Nayoung Kim,et al. Long‐term Follow‐up Helicobacter Pylori Reinfection Rate and Its Associated Factors in Korea , 2013, Helicobacter.
[6] D. J. Kim,et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. , 2012, World journal of gastroenterology.
[7] Jung Mogg Kim,et al. [Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. , 2011, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[8] T. Joh,et al. Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin , 2010, Journal of clinical biochemistry and nutrition.
[9] D. Graham,et al. Helicobacter pylori treatment in the era of increasing antibiotic resistance , 2010, Gut.
[10] Y. Joo,et al. [The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy]. , 2010, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[11] Nayoung Kim,et al. Change in Antibiotic Resistance of Helicobacter pylori Strains and the Effect of A2143G Point Mutation of 23S rRNA on the Eradication of H. pylori in a Single Center of Korea , 2010, Journal of clinical gastroenterology.
[12] Nayoung Kim,et al. [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. , 2009, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[13] W. Cai,et al. Variables Influencing Outcome of Helicobacter pylori Eradication Therapy in South China , 2009, Helicobacter.
[14] S. Futagami,et al. Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole‐Containing Triple Therapy Against Helicobacter pylori Infection Following Clarithromycin‐Containing Triple‐Therapy Failure , 2009, Helicobacter.
[15] H. Lee,et al. Trend in the eradication rates of Helicobacter pylori infection in the last 11 years , 2009 .
[16] Keun Young Shin,et al. The trend in the eradication rates of first- and second-line therapy for Helicobacter pylori infection in Daegu and Kyungpook provinces: a single center experience for the most recent 9 years , 2009 .
[17] Y. Yamaoka,et al. Helicobacter and Gastric Malignancies , 2008, Helicobacter.
[18] S. Hong,et al. [Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication]. , 2007, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[19] F. Mégraud,et al. Helicobacter pylori Detection and Antimicrobial Susceptibility Testing , 2007, Clinical Microbiology Reviews.
[20] Nayoung Kim,et al. [The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years]. , 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[21] K. Matsuo,et al. Smoking increases the treatment failure for Helicobacter pylori eradication. , 2006, The American journal of medicine.
[22] A. Axon,et al. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicateHelicobacter pylori , 2005, Journal of Gastroenterology.
[23] F. Perna,et al. Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection , 2004, American Journal of Gastroenterology.
[24] James Versalovic,et al. Helicobacter pylori. Pathology and diagnostic strategies. , 2003, American journal of clinical pathology.
[25] F. Mégraud,et al. Risk factors for failure of Helicobacter pylori therapy — results of an individual data analysis of 2751 patients , 2003, Alimentary pharmacology & therapeutics.
[26] P. Malfertheiner,et al. Current Standards in the Diagnosis of Helicobacter pylori Infection , 2001, Digestive Diseases.
[27] A. Andriulli,et al. Predictors of failure of Helicobacter pylori eradication with the standard ‘Maastricht triple therapy’ , 2001, Alimentary pharmacology & therapeutics.
[28] D. Graham,et al. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. , 2001, Archives of internal medicine.
[29] A. Blum,et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. , 1995, Gut.
[30] P. Bertazzi,et al. IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
[31] D. Graham,et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. , 1992, Gastroenterology.
[32] L. Holm,et al. Role of blood flow in gastric acid secretion. , 1988, The American journal of physiology.